Navigation Links
DNA2.0 Patents Key Method for Synthesizing Bioplastic Polymer
Date:6/29/2012

Menlo Park, CA (PRWEB) June 29, 2012

DNA2.0 announced that the USPTO has recognized its bioengineering work by awarding the company a new patent. Patent 8,158,391 covers genetic modifications to yeast of the genus Candida that enable them to produce commercially valuable yields of omega hydroxy fatty acids. Until now, these key chemical building blocks could only be produced using synthetic chemistry, making them too expensive for most applications. DNA2.0 expects this new bio-based production route to make hydroxy fatty acids available for the synthesis of lubricants, adhesives and monomers for a unique family of bio-based plastics. Unlike existing bioplastics, this new polymer will have properties very similar to polyethylene, allowing for easy acceptance in the marketplace. The plastics can be used for packaging and other purposes and can afterwards be broken down and turned into diesel fuel.

DNA2.0 collaborated with Professor Richard Gross and his lab at Polytechnic University in Brooklyn, N.Y. to engineer the yeast. The yeast production strain was engineered to produce omega hydroxy fatty acids by identifying and eliminating from the yeast genome 16 genes that had been preventing accumulation of the desired compounds. DNA2.0 then introduced genes encoding different hydroxylation enzymes, allowing Professor Gross' lab to identify those that best produced hydroxyl fatty acids.

“This patent demonstrates the value of DNA2.0’s tools, which have enabled a small team of scientists to rewire a cell for cost-effective production of useful chemicals,” said Jeremy Minshull, cofounder and CEO of DNA2.0. “Weaning ourselves from petrochemicals will require us to develop renewable alternatives without compromising performance. We are proud to leverage our engineering expertise to co-develop solutions with pioneering scientists such as Pro
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
2. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents
3. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
4. New method for producing precursor of neurons, bone and other important tissues from stem cells
5. UCLA team develops highly efficient method for creating flexible, transparent electrodes
6. New method for enhancing thermal conductivity could cool computer chips, lasers and other devices
7. New laboratory method uses mass spectrometry to rapidly detect staph infections
8. Novel method to make nanomaterials discovered
9. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
10. New method yields insulin-producing pancreatic cell clusters
11. X-BODY BioSciences to Present Novel Methods of Selecting for Antibodies Against Targets on Live Cells at CHIs Protein Engineering Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2015)... Equity Research Institute has initiated ... PDLI ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ... Inc. (NASDAQ: NWBO ), and Acorda Therapeutics Inc. ... BioPharma can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=PDLI On ... 5,146.41, down 0.49%, the Dow Jones Industrial Average declined ...
(Date:7/24/2015)... 24, 2015 , Adds integrated ... Expands product offering for chronic kidney disease and oncology ... diabetes-related complications and dermatology , Increases group revenue ... or ,the Company"), a leading China ... marketing biopharmaceutical products, today announced that it has acquired ...
(Date:7/23/2015)... ... , ... One hundred years ago this year, 18 model airplane clubs competed ... of winning the Henry S. Villard Trophy. The Academy of Model Aeronautics has plans ... to build a Free Flight fantasy club worthy of taking home the Villard Trophy. ...
(Date:7/23/2015)... Hutchison China MediTech Limited ... signed a subscription agreement (the "Agreement") and completed ... by Mitsui & Co., Ltd. ("Mitsui") in the ... Limited ("Hutchison MediPharma") (representing 12.24% of the share ... shares in Chi-Med ("Subscription Shares") (representing 5.69% of ...
Breaking Biology Technology:Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 53SBio Acquires Zhejiang Wansheng Pharmaceutical 23SBio Acquires Zhejiang Wansheng Pharmaceutical 33SBio Acquires Zhejiang Wansheng Pharmaceutical 4Academy of Model Aeronautics to Start Online Fantasy Flight Competition 2Mitsui Exchanges its Shares in Hutchison MediPharma for Shares in Chi-Med 2
... Inc.,( http://www.nikoninstruments.com/ ) announced its new SMZ-445/460,stereoscopic zoom ... at a low cost for the Industrial and ... range of applications, from routine,quality control to semiconductor ... to 3.5x zoom magnification, and SMZ-460, 0.7x to,3.0x ...
... SAFE-BioPharma Association First to Offer TriCipher ID Tool ToGo ... Pharmaceutical and ... TriCipher, the strong,authentication company, has created the first SAFE-BioPharma(TM) ... Key Infrastructure,Policy Authority (FPKIPA), the interagency body that enforces ...
... 15, Agendia BV and Ferrer inCode today announced ... sell two of Agendia,s,signature cancer diagnostic services -- ... to indicate risk of breast cancer tumor,recurrence, and ... fast and reliable method of identifying the primary ...
Cached Biology Technology:Nikon Instruments Introduces New Microscopes and Illumination Stand for Education and OEM Markets 2TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) 'Roaming' Credentials 2TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) 'Roaming' Credentials 3TriCipher is First to Transfer Smart Card Level Security to Federally Approved SAFE-BioPharma(TM) 'Roaming' Credentials 4Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets 2Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets 3
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... has announced the addition of the "Natural ... Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image ... to their offering. The key vendors ... Google, HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, ...
(Date:6/30/2015)... HATFIELD, Pa. , June 30, 2015 ... joined the company as CEO to help further develop ... a wealth of partnering experience, having spent much of ... companies including Therakine, Amgen, Baxter Bioscience, and Johnson & ... a focus on Technology and Biotech Corporate Finance. He ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool specifically ... a healthier, happier life. That,s exactly what USANA,s ... do. The cutting-edge, portable health program provides a personalized ... to help improve your lifestyle and nutrition. ... and gala Wednesday night, USANA,s THA was honored with ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... NEW YORK (FEBRUARY 13, 2008) The Wildlife Conservation ... a 5,000 mile-long genetic corridor from Bhutan to Burma ... landscapes. The corridor, first announced at the United Nations ... the largest block of tiger habitat left on earth. ...
... group of the University of Granada has found ... and the olive skin wax extracted from alpeorujo (crushed olive ... regulating apoptosis in carcinogenic processes., Maslinic acid is a protease ... cell growth. It is useful for cancer treatment, as it ...
... snuggle can prematurely end a love affair, as new evidence ... a smokers risk of an early heart attack. Researchers say ... population has a gene defect that delivers a one-two punch ... with this common gene variant experienced a heart attack around ...
Cached Biology News:'Genetic corridors' are next step to saving tigers 2'Genetic corridors' are next step to saving tigers 3A compound extracted from olives inhibits cancer cells growth and prevents their appearance 2Cigarette after Valentine snuggle deadlier for some 2Cigarette after Valentine snuggle deadlier for some 3
MOUSE ANTI RABBIT T LYMPHOCTYES Immunogen: Rabbit Thymocytes...
Normal canine serum collected from healthy normal canines....
RABBIT ANTI HUMAN CYTOCHROME P450 1A1/2 Immunogen: Purified human CYP1A2 expressed in E.Coli ...
... Error-free cloning of BAC (100+kb), fosmid ... Greater insert stability than any othe BAC ... for high yields and easy recombinant DNA ... or transcription-free (pSMART VC) vectors for the ...
Biology Products: